Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin
FLAVELL, D. J, BOEHM, D. A, NOSS, A, WARNES, S. L, FLAVELL, S. U
Published in British journal of cancer (01.02.2001)
Published in British journal of cancer (01.02.2001)
Get full text
Journal Article
Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours
FLAVELL, D. J, FLAVELL, S. U, BOEHM, D. A, EMERY, L, NOSS, A, LING, N. R, RICHARDSON, P. R, HARDIE, D, WRIGHT, D. H
Published in British journal of cancer (01.12.1995)
Published in British journal of cancer (01.12.1995)
Get full text
Journal Article
Systemic therapy with 3BIT, a triple combination cocktail of anti-CD19, -CD22, and -CD38-saporin immunotoxins, is curative of human B-cell lymphoma in severe combined immunodeficient mice
FLAVELL, D. J, NOSS, A, PULFORD, K. A. F, LING, N, FLAVELL, S. U
Published in Cancer research (Chicago, Ill.) (01.11.1997)
Get full text
Published in Cancer research (Chicago, Ill.) (01.11.1997)
Journal Article
Host-mediated antibody-dependent cellular cytotoxicity contributes to the in vivo therapeutic efficacy of an anti-CD7-saporin immunotoxin in a severe combined immunodeficient mouse model of human T-cell acute lymphoblastic leukemia
FLAVELL, D. J, WARNES, S, NOSS, A, FLAVELL, S. U
Published in Cancer research (Chicago, Ill.) (15.12.1998)
Get full text
Published in Cancer research (Chicago, Ill.) (15.12.1998)
Journal Article
Localisation of granulocyte macrophage colony-stimulating factor in human long-term bone marrow cultures : biological and immunocytochemical characterisation
DE WYNTER, E, ALLEN, T, COUTINHO, L, FLAVELL, D, FLAVELL, S. U, DEXTER, T. M
Published in Journal of cell science (01.11.1993)
Published in Journal of cell science (01.11.1993)
Get full text
Journal Article
Therapy of human B-cell lymphoma bearing SCID mice is more effective with anti-CD19- and anti-CD38-saporin immunotoxins used in combination than with either immunotoxin used alone
Flavell, D J, Boehm, D A, Emery, L, Noss, A, Ramsay, A, Flavell, S U
Published in International journal of cancer (28.07.1995)
Published in International journal of cancer (28.07.1995)
Get more information
Journal Article
Effectiveness of combinations of bispecific antibodies for delivering saporin to human acute T-cell lymphoblastic leukaemia cell lines via CD7 and CD38 as cellular target molecules
FLAVELL, D. J, COOPER, S, MORLAND, B, FRENCH, R, FLAVELL, S. U
Published in British journal of cancer (01.04.1992)
Published in British journal of cancer (01.04.1992)
Get full text
Journal Article
Effectiveness of HB2 (anti-CD7)--saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice
Morland, B J, Barley, J, Boehm, D, Flavell, S U, Ghaleb, N, Kohler, J A, Okayama, K, Wilkins, B, Flavell, D J
Published in British journal of cancer (01.02.1994)
Published in British journal of cancer (01.02.1994)
Get full text
Journal Article
Therapy of human T-cell acute lymphoblastic leukaemia in severe combined immunodeficient mice with two different anti-CD7-saporin immunotoxins containing hindered or non-hindered disulphide cross-linkers
Flavell, D J, Boehm, D A, Okayama, K, Kohler, J A, Flavell, S U
Published in International journal of cancer (01.08.1994)
Published in International journal of cancer (01.08.1994)
Get more information
Journal Article
Comparison of the performance of anti-CD7 and anti-CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T-cell acute lymphoblastic leukemia cell line
Flavell, D J, Cooper, S, Okayama, K, Emery, L, Flavell, S U
Published in Hematological oncology (1995)
Published in Hematological oncology (1995)
Get more information
Journal Article